Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 4 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 29, 2026 Filed Feb 2, 2026 22:19 UTC |
Quartel Adrian WChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $8.86 | $0.00 |
DisclosureSEC source: 0001910132-26-000002 · wk-form4_1770070750.xml · derivative · entry 4 Quartel Adrian W · CIK 0001910132 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2036-01-28 F5 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan. The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 22:19 UTC |
Quartel Adrian WChief Medical Officer
|
GrantRestricted Stock Unit · Derivative | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001910132-26-000002 · wk-form4_1770070750.xml · derivative · entry 3 Quartel Adrian W · CIK 0001910132 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on January 29, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date. F4 · derivative.expiration_date: The restricted stock units will vest and settle as to one third of the restricted stock units on January 29, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 22:19 UTC | GrantStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $8.86 | $0.00 |
DisclosureSEC source: 0001945557-26-000002 · wk-form4_1770070744.xml · derivative · entry 5 Schafer Joshua · CIK 0001945557 · CCO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2036-01-28 F5 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan. The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. Read SEC document |
|
| January 29, 2026 Filed Feb 2, 2026 22:19 UTC | GrantRestricted Stock Unit · Derivative | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001945557-26-000002 · wk-form4_1770070744.xml · derivative · entry 4 Schafer Joshua · CIK 0001945557 · CCO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on January 29, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date. F4 · derivative.expiration_date: The restricted stock units will vest and settle as to one third of the restricted stock units on January 29, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date. Read SEC document |
|
| January 29, 2026 Filed Feb 2, 2026 22:18 UTC |
McFarlane Neil F.Director · President and CEO
|
GrantStock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $8.86 | $0.00 |
DisclosureSEC source: 0001681098-26-000002 · wk-form4_1770070730.xml · derivative · entry 4 McFarlane Neil F. · CIK 0001681098 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2036-01-28 F5 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan. The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 22:18 UTC |
McFarlane Neil F.Director · President and CEO
|
GrantRestricted Stock Unit · Derivative | 125,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001681098-26-000002 · wk-form4_1770070730.xml · derivative · entry 3 McFarlane Neil F. · CIK 0001681098 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on January 29, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date. F4 · derivative.expiration_date: The restricted stock units will vest and settle as to one third of the restricted stock units on January 29, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date. Read SEC document |
| December 31, 2025 Filed Jan 7, 2026 16:18 UTC |
Clifton R. LaDuaneFormer CFO & Treasurer
|
Exercise / conversionPerformance Stock Unit · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001488774-26-000002 · wk-form4_1767820678.xml · derivative · entry 5 Clifton R. LaDuane · CIK 0001488774 · Former CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025. F4 · derivative.expiration_date: The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025. Read SEC document |
| December 31, 2025 Filed Jan 7, 2026 16:18 UTC |
Clifton R. LaDuaneFormer CFO & Treasurer
|
Exercise / conversionRestricted Stock Unit · Derivative | 34,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001488774-26-000002 · wk-form4_1767820678.xml · derivative · entry 4 Clifton R. LaDuane · CIK 0001488774 · Former CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 34,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025. F4 · derivative.expiration_date: The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025. Read SEC document |
| December 31, 2025 Filed Jan 7, 2026 16:18 UTC |
Clifton R. LaDuaneFormer CFO & Treasurer
|
Exercise / conversionRestricted Stock Unit · Derivative | 86,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001488774-26-000002 · wk-form4_1767820678.xml · derivative · entry 3 Clifton R. LaDuane · CIK 0001488774 · Former CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 86,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025. F4 · derivative.expiration_date: The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025. Read SEC document |
| December 31, 2025 Filed Jan 7, 2026 16:18 UTC |
Clifton R. LaDuaneFormer CFO & Treasurer
|
Tax withholdingCommon Stock | 48,513 | $8.96 | $434,676.48 |
DisclosureSEC source: 0001488774-26-000002 · wk-form4_1767820678.xml · nonDerivative · entry 2 Clifton R. LaDuane · CIK 0001488774 · Former CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,515 F2 · shares: Shares withheld to cover withholding taxes for the vested restricted stock units and performance stock units. Read SEC document |
| December 31, 2025 Filed Jan 7, 2026 16:18 UTC |
Clifton R. LaDuaneFormer CFO & Treasurer
|
Exercise / conversionCommon Stock | 140,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001488774-26-000002 · wk-form4_1767820678.xml · nonDerivative · entry 1 Clifton R. LaDuane · CIK 0001488774 · Former CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,028 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares issued upon vesting of restricted stock units and performance stock units on December 31, 2025. Read SEC document |
| December 02, 2025 Filed Dec 9, 2025 21:18 UTC |
Secor AliciaDirector
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $8.17 | $0.00 |
DisclosureSEC source: 0001584516-25-000009 · wk-form4_1765315079.xml · derivative · entry 1 Secor Alicia · CIK 0001584516 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2035-12-01 F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, December 2, 2025. F2 · derivative.exercise_date: The option will vest and become exercisable as follows: (1) in three equal installments on the each of the dates that are one day prior to the first three annual stockholder meetings occurring after the grant date, or (2) immediately prior to a Change in Control, subject in each case to the director's continued service on such vesting date. Read SEC document |
| October 10, 2025 Filed Oct 10, 2025 23:17 UTC |
McFarlane Neil F.Director · President and CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 50,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001681098-25-000005 · wk-form4_1760138252.xml · derivative · entry 3 McFarlane Neil F. · CIK 0001681098 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 50,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: 25% of the RSUs vested and settled on each of October 10, 2024 and October 10, 2025. The remaining 50% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates the Reporting Person's employment relationship has not been terminated as defined in the Issuer's 2023 Employment Inducement Award Plan. All shares will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. F3 · derivative.expiration_date: 25% of the RSUs vested and settled on each of October 10, 2024 and October 10, 2025. The remaining 50% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates the Reporting Person's employment relationship has not been terminated as defined in the Issuer's 2023 Employment Inducement Award Plan. All shares will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. Read SEC document |
| October 10, 2025 Filed Oct 10, 2025 23:17 UTC |
McFarlane Neil F.Director · President and CEO
|
SaleCommon Stock | 19,500 | $10.82 | $210,908.10 |
DisclosureSEC source: 0001681098-25-000005 · wk-form4_1760138252.xml · nonDerivative · entry 2 McFarlane Neil F. · CIK 0001681098 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 222,016 F2 · kind: Adoption date of referenced 10b5-1(c) plan is: 03-21-2025. Read SEC document |
| October 10, 2025 Filed Oct 10, 2025 23:17 UTC |
McFarlane Neil F.Director · President and CEO
|
Exercise / conversionCommon Stock | 50,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681098-25-000005 · wk-form4_1760138252.xml · nonDerivative · entry 1 McFarlane Neil F. · CIK 0001681098 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 241,516 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| September 12, 2025 Filed Sep 15, 2025 20:07 UTC |
Shih AlvinDirector
|
PurchaseCommon Stock | 20,000 | $7.89 | $157,800.00 |
DisclosureSEC source: 0001610064-25-000011 · wk-form4_1757966847.xml · nonDerivative · entry 1 Shih Alvin · CIK 0001610064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.85 to $7.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| September 12, 2025 Filed Sep 16, 2025 20:15 UTC |
FAVORITO TAMARA ADirector
|
PurchaseCommon Stock | 3,175 | $7.79 | $24,718.01 |
DisclosureSEC source: 0001288232-25-000009 · wk-form4_1758053735.xml · nonDerivative · entry 1 FAVORITO TAMARA A · CIK 0001288232 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,894 Read SEC document |
| August 19, 2025 Filed Aug 20, 2025 20:38 UTC |
Bode John BDirector
|
PurchaseCommon Stock | 5,000 | $9.17 | $45,825.00 |
DisclosureSEC source: 0001437749-25-027456 · rdgdoc.xml · nonDerivative · entry 1 Bode John B · CIK 0001612084 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Read SEC document |
| June 26, 2025 Filed Jun 30, 2025 21:02 UTC |
Thompson RahsaanChief Legal & Compliance · Secretary
|
SaleCommon Stock | 24,000 | $9.21 | $221,004.00 |
DisclosureSEC source: 0001437749-25-021577 · rdgdoc.xml · nonDerivative · entry 1 Thompson Rahsaan · CIK 0001788524 · Chief Legal & Compliance · Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,666 F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 03-27-2025 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.11 to $9.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| June 21, 2025 Filed Jun 24, 2025 21:28 UTC |
Thompson RahsaanChief Legal & Compliance · Secretary
|
Exercise / conversionRestricted Stock Unit · Derivative | 66,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-021183 · rdgdoc.xml · derivative · entry 2 Thompson Rahsaan · CIK 0001788524 · Chief Legal & Compliance · Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,334 Underlying: Common Stock · 66,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The first tranche of the restricted stock units vested and settled on June 21, 2025, and the remaining two tranches of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date. F2 · derivative.expiration_date: The first tranche of the restricted stock units vested and settled on June 21, 2025, and the remaining two tranches of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date. Read SEC document |
| June 21, 2025 Filed Jun 24, 2025 21:28 UTC |
Thompson RahsaanChief Legal & Compliance · Secretary
|
Exercise / conversionCommon Stock | 66,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-021183 · rdgdoc.xml · nonDerivative · entry 1 Thompson Rahsaan · CIK 0001788524 · Chief Legal & Compliance · Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed May 31, 2025 01:38 UTC |
Watton Corey MichaelDirector
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $8.62 | $0.00 |
DisclosureSEC source: 0001437749-25-019046 · rdgdoc.xml · derivative · entry 1 Watton Corey Michael · CIK 0001975404 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2035-05-28 F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 29, 2025. F2 · shares: This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy. F3 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date. Read SEC document |
| May 29, 2025 Filed May 31, 2025 01:38 UTC |
Bode John BDirector
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $8.62 | $0.00 |
DisclosureSEC source: 0001437749-25-019045 · rdgdoc.xml · derivative · entry 1 Bode John B · CIK 0001612084 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2035-05-28 F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 29, 2025. F2 · shares: This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy. F3 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date. Read SEC document |
| May 29, 2025 Filed May 31, 2025 01:41 UTC |
Shih AlvinDirector
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $8.62 | $0.00 |
DisclosureSEC source: 0001437749-25-019050 · rdgdoc.xml · derivative · entry 1 Shih Alvin · CIK 0001610064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2035-05-28 F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 29, 2025. F2 · shares: This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy. F3 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date. Read SEC document |
| May 29, 2025 Filed May 31, 2025 01:40 UTC |
DIXON WENDY LDirector
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $8.62 | $0.00 |
DisclosureSEC source: 0001437749-25-019049 · rdgdoc.xml · derivative · entry 1 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2035-05-28 F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 29, 2025. F2 · shares: This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy. F3 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date. Read SEC document |
| May 29, 2025 Filed May 31, 2025 01:39 UTC |
Calder Douglas WDirector
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $8.62 | $0.00 |
DisclosureSEC source: 0001437749-25-019048 · rdgdoc.xml · derivative · entry 1 Calder Douglas W · CIK 0001510445 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2035-05-28 F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 29, 2025. F2 · shares: This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy. F3 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date. Read SEC document |
| May 29, 2025 Filed May 31, 2025 01:39 UTC |
FAVORITO TAMARA ADirector
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $8.62 | $0.00 |
DisclosureSEC source: 0001437749-25-019047 · rdgdoc.xml · derivative · entry 1 FAVORITO TAMARA A · CIK 0001288232 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2035-05-28 F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 29, 2025. F2 · shares: This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy. F3 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date. Read SEC document |
| May 29, 2025 Filed May 31, 2025 01:37 UTC |
Anderson ThomasDirector
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $8.62 | $0.00 |
DisclosureSEC source: 0001437749-25-019044 · rdgdoc.xml · derivative · entry 1 Anderson Thomas · CIK 0001612903 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2035-05-28 F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 29, 2025. F2 · shares: This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy. F3 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date. Read SEC document |
| March 28, 2025 Filed Apr 1, 2025 00:05 UTC |
Watton Corey MichaelDirector
|
PurchaseCommon Stock | 300 | $7.84 | $2,351.52 |
DisclosureSEC source: 0001437749-25-010332 · rdgdoc.xml · nonDerivative · entry 1 Watton Corey Michael · CIK 0001975404 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,800 Read SEC document |
| March 19, 2025 Filed Mar 21, 2025 20:06 UTC |
Bode John BDirector
|
PurchaseCommon Stock | 10,000 | $7.96 | $79,624.00 |
DisclosureSEC source: 0001437749-25-008738 · rdgdoc.xml · nonDerivative · entry 1 Bode John B · CIK 0001612084 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.91 to $8.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| February 14, 2025 Filed Feb 14, 2025 22:54 UTC |
McFarlane Neil F.Director · President and CEO
|
SaleCommon Stock | 30,544 | $8.05 | $245,961.67 |
DisclosureSEC source: 0001437749-25-004067 · rdgdoc.xml · nonDerivative · entry 2 McFarlane Neil F. · CIK 0001681098 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 191,516 F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 10-15-2024 Read SEC document |
| February 13, 2025 Filed Feb 14, 2025 17:55 UTC |
Clifton R. LaDuaneCFO & Treasurer
|
SaleCommon Stock | 11,000 | $7.86 | $86,471.00 |
DisclosureSEC source: 0001437749-25-004068 · rdgdoc.xml · nonDerivative · entry 1 Clifton R. LaDuane · CIK 0001488774 · CFO & Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,361 F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 10/15/2024 Read SEC document |
| February 13, 2025 Filed Feb 14, 2025 22:55 UTC |
Schafer JoshuaCCO & EVP, Bus. Development
|
SaleCommon Stock | 10,500 | $7.86 | $82,526.85 |
DisclosureSEC source: 0001437749-25-004069 · rdgdoc.xml · nonDerivative · entry 1 Schafer Joshua · CIK 0001945557 · CCO & EVP, Bus. Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,486 F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 10/15/2024 Read SEC document |
| February 13, 2025 Filed Feb 14, 2025 22:57 UTC |
Sangiovanni Timothy J.SVP, Finance & Corp Controller
|
SaleCommon Stock | 3,000 | $7.86 | $23,587.80 |
DisclosureSEC source: 0001437749-25-004070 · rdgdoc.xml · nonDerivative · entry 1 Sangiovanni Timothy J. · CIK 0001698328 · SVP, Finance & Corp Controller 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,341 F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 10-15-2024 Read SEC document |
| February 13, 2025 Filed Feb 14, 2025 22:54 UTC |
McFarlane Neil F.Director · President and CEO
|
SaleCommon Stock | 61,273 | $7.86 | $481,428.09 |
DisclosureSEC source: 0001437749-25-004067 · rdgdoc.xml · nonDerivative · entry 1 McFarlane Neil F. · CIK 0001681098 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 222,060 F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 10-15-2024 Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 22:37 UTC |
McFarlane Neil F.Director · President and CEO
|
GrantRestricted Stock Unit · Derivative | 112,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-003328 · rdgdoc.xml · derivative · entry 2 McFarlane Neil F. · CIK 0001681098 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,500 Underlying: Common Stock · 112,500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on February 7, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date. F3 · derivative.expiration_date: The restricted stock units will vest and settle as to one third of the restricted stock units on February 7, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 22:37 UTC |
McFarlane Neil F.Director · President and CEO
|
GrantStock Option (right to buy) · Derivative | 225,000 | $0.00 Strike: $7.77 | $0.00 |
DisclosureSEC source: 0001437749-25-003328 · rdgdoc.xml · derivative · entry 1 McFarlane Neil F. · CIK 0001681098 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,000 Underlying: Common Stock · 225,000 shares Expires 2035-02-06 F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant. Read SEC document |
| January 31, 2025 Filed Feb 3, 2025 17:20 UTC |
Clifton R. LaDuaneCFO & Treasurer
|
Exercise / conversionRestricted Stock Unit · Derivative | 43,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-002625 · rdgdoc.xml · derivative · entry 2 Clifton R. LaDuane · CIK 0001488774 · CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,667 Underlying: Common Stock · 43,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle inequal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date. F2 · derivative.expiration_date: The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle inequal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date. Read SEC document |
| January 31, 2025 Filed Feb 3, 2025 17:20 UTC |
Clifton R. LaDuaneCFO & Treasurer
|
Exercise / conversionCommon Stock | 43,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-002625 · rdgdoc.xml · nonDerivative · entry 1 Clifton R. LaDuane · CIK 0001488774 · CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,361 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 31, 2025 Filed Feb 3, 2025 22:24 UTC |
Sangiovanni Timothy J.SVP, Finance & Corp Controller
|
Exercise / conversionRestricted Stock Unit · Derivative | 11,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-002629 · rdgdoc.xml · derivative · entry 2 Sangiovanni Timothy J. · CIK 0001698328 · SVP, Finance & Corp Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,334 Underlying: Common Stock · 11,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle inequal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date. F2 · derivative.expiration_date: The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle inequal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date. Read SEC document |
| January 31, 2025 Filed Feb 3, 2025 22:24 UTC |
Sangiovanni Timothy J.SVP, Finance & Corp Controller
|
Exercise / conversionCommon Stock | 11,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-002629 · rdgdoc.xml · nonDerivative · entry 1 Sangiovanni Timothy J. · CIK 0001698328 · SVP, Finance & Corp Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,341 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 31, 2025 Filed Feb 3, 2025 22:22 UTC |
Schafer JoshuaCCO & EVP, Bus. Development
|
Exercise / conversionRestricted Stock Unit · Derivative | 35,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-002627 · rdgdoc.xml · derivative · entry 2 Schafer Joshua · CIK 0001945557 · CCO & EVP, Bus. Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,667 Underlying: Common Stock · 35,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle inequal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date. F2 · derivative.expiration_date: The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle inequal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date. Read SEC document |
| January 31, 2025 Filed Feb 3, 2025 22:22 UTC |
Schafer JoshuaCCO & EVP, Bus. Development
|
Exercise / conversionCommon Stock | 35,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-002627 · rdgdoc.xml · nonDerivative · entry 1 Schafer Joshua · CIK 0001945557 · CCO & EVP, Bus. Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 31, 2025 Filed Feb 3, 2025 22:19 UTC |
McFarlane Neil F.Director · President and CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 233,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-002623 · rdgdoc.xml · derivative · entry 2 McFarlane Neil F. · CIK 0001681098 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 466,667 Underlying: Common Stock · 233,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date. F2 · derivative.expiration_date: The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date. Read SEC document |
| January 31, 2025 Filed Feb 3, 2025 22:19 UTC |
McFarlane Neil F.Director · President and CEO
|
Exercise / conversionCommon Stock | 233,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-002623 · rdgdoc.xml · nonDerivative · entry 1 McFarlane Neil F. · CIK 0001681098 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 283,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 30, 2025 Filed Feb 3, 2025 17:20 UTC |
Clifton R. LaDuaneCFO & Treasurer
|
GrantRestricted Stock Unit · Derivative | 34,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-002625 · rdgdoc.xml · derivative · entry 4 Clifton R. LaDuane · CIK 0001488774 · CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,000 Underlying: Common Stock · 34,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on January 30, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date. F4 · derivative.expiration_date: The restricted stock units will vest and settle as to one third of the restricted stock units on January 30, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date. Read SEC document |
| January 30, 2025 Filed Feb 3, 2025 17:20 UTC |
Clifton R. LaDuaneCFO & Treasurer
|
GrantStock Option (right to buy) · Derivative | 68,000 | $0.00 Strike: $8.02 | $0.00 |
DisclosureSEC source: 0001437749-25-002625 · rdgdoc.xml · derivative · entry 3 Clifton R. LaDuane · CIK 0001488774 · CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,000 Underlying: Common Stock · 68,000 shares Expires 2035-01-29 F3 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant. Read SEC document |
| January 30, 2025 Filed Feb 3, 2025 22:23 UTC |
Thompson RahsaanChief Legal & Compliance · Secretary
|
GrantRestricted Stock Unit · Derivative | 34,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-002628 · rdgdoc.xml · derivative · entry 2 Thompson Rahsaan · CIK 0001788524 · Chief Legal & Compliance · Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,000 Underlying: Common Stock · 34,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on January 30, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date. F3 · derivative.expiration_date: The restricted stock units will vest and settle as to one third of the restricted stock units on January 30, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date. Read SEC document |
| January 30, 2025 Filed Feb 3, 2025 22:23 UTC |
Thompson RahsaanChief Legal & Compliance · Secretary
|
GrantStock Option (right to buy) · Derivative | 68,000 | $0.00 Strike: $8.02 | $0.00 |
DisclosureSEC source: 0001437749-25-002628 · rdgdoc.xml · derivative · entry 1 Thompson Rahsaan · CIK 0001788524 · Chief Legal & Compliance · Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,000 Underlying: Common Stock · 68,000 shares Expires 2035-01-29 F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant. Read SEC document |
| January 30, 2025 Filed Feb 3, 2025 22:24 UTC |
Sangiovanni Timothy J.SVP, Finance & Corp Controller
|
GrantRestricted Stock Unit · Derivative | 19,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-002629 · rdgdoc.xml · derivative · entry 4 Sangiovanni Timothy J. · CIK 0001698328 · SVP, Finance & Corp Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,000 Underlying: Common Stock · 19,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on January 30, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date. F4 · derivative.expiration_date: The restricted stock units will vest and settle as to one third of the restricted stock units on January 30, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.